(Q34615704)

3 August 2017

Prognostic value of serum free light chain ratio at diagnosis in multiple myeloma (English)

1 reference

3 August 2017

Marie-Christine Kyrtsonis

1

1 reference

3 August 2017

Theodoros P Vassilakopoulos

2

1 reference

3 August 2017

Nicoletta Kafasi

3

1 reference

3 August 2017

Sotirios Sachanas

4

1 reference

3 August 2017

Tatiana Tzenou

5

1 reference

3 August 2017

Argiroula Papadogiannis

6

1 reference

3 August 2017

Zacharoula Galanis

7

1 reference

3 August 2017

Christina Kalpadakis

8

1 reference

3 August 2017

Maria Dimou

9

1 reference

3 August 2017

Elias Kyriakou

10

1 reference

3 August 2017

Maria K Angelopoulou

11

1 reference

3 August 2017

Maria N Dimopoulou

12

1 reference

3 August 2017

Marina P Siakantaris

13

1 reference

3 August 2017

Evangelia M Dimitriadou

14

1 reference

3 August 2017

Styliani I Kokoris

15

1 reference

3 August 2017

Panayiotis Panayiotidis

16

1 reference

3 August 2017

Gerassimos A Pangalis

17

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 May 2007

1 reference

British Journal of Haematology

3 August 2017

1 reference

3 August 2017

137

1 reference

3 August 2017

3

1 reference

3 August 2017

240-243

1 reference

Serum test for assessment of patients with Bence Jones myeloma

3 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06561.X

Expression of the inhibitory receptor ILT3 on dendritic cells is dispensable for induction of CD4+Foxp3+ regulatory T cells by 1,25-dihydroxyvitamin D3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06561.X

Immunoglobulin free light chains and solitary plasmacytoma of bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06561.X

Serum free light-chain measurements for identifying and monitoring patients with nonsecretory multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06561.X

International uniform response criteria for multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06561.X

International staging system for multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06561.X

Outcome in systemic AL amyloidosis in relation to changes in concentration of circulating free immunoglobulin light chains following chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06561.X

Serum free light chains for monitoring multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06561.X

Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06561.X

Effects of paraprotein heavy and light chain types and free light chain load on survival in myeloma: an analysis of patients receiving conventional-dose chemotherapy in Medical Research Council UK multiple myeloma trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06561.X

10.1111/J.1365-2141.2007.06561.X

21 January 2018

Identifiers

DOI

1 reference

3 August 2017

1 reference